BONESUPPORT Q4: Sales estimates beat again - Redeye

Redeye returns with a more in-depth take on BONESUPPORT’s Q4 report, rendering some changes to our financial estimates. We are encouraged by the US CERAMENT G sales in the quarter and up our estimates for this product in the US for 2023e. Moreover, we increase our fair value range considerably.

Länk till analysen i sin helhet: https://www.redeye.se/research/878903/bonesupport-q4-sales-estimates-beat-again?utm_source=finwire&utm_medium=RSS